Home › Products › Oncology › Adcilib 125mg Capsule
Adcilib 125mg Capsule
Salt Composition: PALBOCICLIB
- Manufacturer: ADLEY FORMULATIONS
- Pack Size: 21 CAPSULE(s) IN A BOTTLE
- Dosage Form: CAPSULE
- Strength: 125MG
- Prescription Required
- Storage: Keep Adcilib 125 mg capsule out of sight and reach of children. Store at 20°C to 25°C.
₹5487.00₹7838.00
Inclusive of all taxes
Product Introduction
Adcilib 125 mg Capsule is a targeted therapy containing palbociclib. It belongs to the class of anticancer medications called cyclin-dependent kinase inhibitors. It is indicated for the treatment of hormone receptor-positive, human epidermal growth factor 2 negative advanced or metastatic breast cancer. It is administered in combination with certain other anticancer agents.
Common side effects associated with Adcilib 125 mg Capsule include nausea, vomiting, diarrhoea, fatigue, alopecia, dry skin, rash, infections, epistaxis, decreased appetite, low blood cell counts, oedema of the lips and mouth, dysgeusia, dry eye, blurred vision, and increased lacrimation. Inform your doctor if any of these side effects persist or cause concern.
Before starting this medicine, inform your doctor if you are allergic to Adcilib 125 mg Capsule or any of its ingredients. It is important to notify your healthcare provider of any existing infections (fever, chills, or sore throat), liver disease, kidney disease, or intolerance to certain sugars. Seek immediate medical attention if you experience dry cough, chest pain, or difficulty breathing, as these may indicate lung inflammation.
Provide your physician with a complete list of all medications you are taking, including supplements and herbal medicines, before commencing treatment. Use effective contraception during treatment and for at least three weeks after the final dose. Adcilib 125 mg Capsule is not recommended for patients under 18 years of age.
Alternative brands containing the same active ingredient include Palbace, Palborest, and Palbicip.
Uses
Adcilib 125mg uses are: Treatment of hormone receptor (HR)-positive, human epidermal growth factor 2 (HER2)-negative advanced or metastatic breast cancer.
How it works
Adcilib 125 mg capsule works by blocking the protein called cyclin-dependent kinases 4 and 6, which are vital for the division and growth of cells. By blocking these proteins, this medication slows the growth and prevents the cancer cells from spreading.
How to Use
Take Adcilib 125 mg capsule exactly as prescribed by your doctor. Take this medication once a day at the same time with food. Swallow this capsule as a whole with a glass of water. Avoid crushing, breaking, or chewing the capsule.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. Serious: Blood disorder (fever, chills, shortness of breath, weakness, bleeding, or bruising) Lung inflammation (chest pain, dry cough, or difficulty breathing) Common: Tiredness Hair loss Dry skin, rash Infections Low blood cell counts Decreased of appetite Nausea, vomiting Diarrhea Swelling of lips and mouth Changes in taste Nose bleed Dry eye, blurred vision, increased tearing
References
- Pfizer Limited, Electronic medicines compendium (emc), [Revised on June 2021] [ Accessed on 26 Nov 2022], https://www.medicines.org.uk/emc/files/pil.4449.pdf
- Pfizer Labs, US Food and Drug Administration, [Revised on March 2017] [ Accessed on 26 Nov 2022], https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207103s004lbl.pdf
- Neha S Mangini et al; Palbociclib: A Novel Cyclin-Dependent Kinase Inhibitor for Hormone Receptor-Positive Advanced Breast Cancer; The Annals of Pharmacotherapy; Published on Nov 2015; Accessed on 26/11/2022; https://pubmed.ncbi.nlm.nih.gov/26324355/
- Palbace; Pfizer; Revised on Oct 2021; Accessed on 26/11/2022; https://labeling.pfizer.com/ShowLabeling.aspx?id=14029
Safety Advice
Pregnancy: unsafe It is not recommended to take Adcilib 125 mg capsule during pregnancy as it can harm the unborn baby. Women with childbearing potential should use effective contraceptives during treatment and for at least three weeks after treatment.
Lungs: Consult your doctor It is not unknown whether Adcilib 125 mg Capsule can be administered to patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.
Breastfeeding: unsafe It is not recommended to take Adcilib 125 mg capsule while breastfeeding as it is not known whether it passes into the breast milk.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.